Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffery P Struewing

Showing results (11-20 of 46) with videos related to

Pageof 5
Sort By:
American Journal of Medical Genetics. Part A|September 14, 2006
BRCA1/2 testing in hereditary breast and ovarian cancer families III: risk perception and screeningAideen McInerney-Leo, Donald Hadley, Ronald G Kase, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 30, 2005
Prophylactic oophorectomy reduces breast cancer penetrance during prospective, long-term follow-up of BRCA1 mutation carriersJoan L Kramer, Isela A Velazquez, Bingshu E Chen, et al.
Journal of the National Cancer Institute|August 21, 2003
Re: Population-based, case-control study of HER2 genetic polymorphism and breast cancer riskMichael Hauptmann, Alice J Sigurdson, Nilanjan Chatterjee, et al.
BMC Cancer|April 29, 2004
Kin-cohort estimates for familial breast cancer risk in relation to variants in DNA base excision repair, BRCA1 interacting and growth factor genesAlice J Sigurdson, Michael Hauptmann, Nilanjan Chatterjee, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 16, 2007
Papillary thyroid cancer and polymorphic variants in TSHR- and RET-related genes: a nested case-control study within a cohort of U.S. radiologic technologistsStefan Lönn, Parveen Bhatti, Bruce H Alexander, et al.
Breast Cancer Research and Treatment|May 12, 2010
No evidence of excess breast cancer risk among mutation-negative women from BRCA mutation-positive familiesLarissa A Korde, Christine M Mueller, Jennifer T Loud, et al.
Mutation Research|August 16, 2005
DNA damage among thyroid cancer and multiple cancer cases, controls, and long-lived individualsAlice J Sigurdson, Michael Hauptmann, Bruce H Alexander, et al.
Journal of the National Cancer Institute|July 17, 2003
Gynecologic surgeries and risk of ovarian cancer in women with BRCA1 and BRCA2 Ashkenazi founder mutations: an Israeli population-based case-control studyJoni L Rutter, Sholom Wacholder, Angela Chetrit, et al.
American Journal of Medical Genetics. Part A|September 21, 2004
BRCA1/2 testing in hereditary breast and ovarian cancer families: effectiveness of problem-solving training as a counseling interventionAideen McInerney-Leo, Barbara Bowles Biesecker, Donald W Hadley, et al.
American Journal of Medical Genetics. Part A|January 6, 2005
BRCA1/2 testing in hereditary breast and ovarian cancer families II: impact on relationshipsAideen McInerney-Leo, Barbara Bowles Biesecker, Donald W Hadley, et al.
Pageof 5

Showing results (11-20 of 46) with videos related to

Sort By:
Pageof 5
American Journal of Medical Genetics. Part A|September 14, 2006
BRCA1/2 testing in hereditary breast and ovarian cancer families III: risk perception and screeningAideen McInerney-Leo, Donald Hadley, Ronald G Kase, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 30, 2005
Prophylactic oophorectomy reduces breast cancer penetrance during prospective, long-term follow-up of BRCA1 mutation carriersJoan L Kramer, Isela A Velazquez, Bingshu E Chen, et al.
Journal of the National Cancer Institute|August 21, 2003
Re: Population-based, case-control study of HER2 genetic polymorphism and breast cancer riskMichael Hauptmann, Alice J Sigurdson, Nilanjan Chatterjee, et al.
BMC Cancer|April 29, 2004
Kin-cohort estimates for familial breast cancer risk in relation to variants in DNA base excision repair, BRCA1 interacting and growth factor genesAlice J Sigurdson, Michael Hauptmann, Nilanjan Chatterjee, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 16, 2007
Papillary thyroid cancer and polymorphic variants in TSHR- and RET-related genes: a nested case-control study within a cohort of U.S. radiologic technologistsStefan Lönn, Parveen Bhatti, Bruce H Alexander, et al.
Breast Cancer Research and Treatment|May 12, 2010
No evidence of excess breast cancer risk among mutation-negative women from BRCA mutation-positive familiesLarissa A Korde, Christine M Mueller, Jennifer T Loud, et al.
Mutation Research|August 16, 2005
DNA damage among thyroid cancer and multiple cancer cases, controls, and long-lived individualsAlice J Sigurdson, Michael Hauptmann, Bruce H Alexander, et al.
Journal of the National Cancer Institute|July 17, 2003
Gynecologic surgeries and risk of ovarian cancer in women with BRCA1 and BRCA2 Ashkenazi founder mutations: an Israeli population-based case-control studyJoni L Rutter, Sholom Wacholder, Angela Chetrit, et al.
American Journal of Medical Genetics. Part A|September 21, 2004
BRCA1/2 testing in hereditary breast and ovarian cancer families: effectiveness of problem-solving training as a counseling interventionAideen McInerney-Leo, Barbara Bowles Biesecker, Donald W Hadley, et al.
American Journal of Medical Genetics. Part A|January 6, 2005
BRCA1/2 testing in hereditary breast and ovarian cancer families II: impact on relationshipsAideen McInerney-Leo, Barbara Bowles Biesecker, Donald W Hadley, et al.
Pageof 5